Rapid Communication: Period2 gene silencing increases the synthesis of α^sub s^-casein protein in bovine mammary epithelial cells 1
Period2 (PER2), a core clock gene, encodes a circadian rhythm protein which has been shown to control mammary metabolism in rodents. Whether PER2 regulates milk component synthesis such as αs-casein protein in bovine mammary cells is unknown. Thus, we used gene silencing technology to determine if P...
Saved in:
Published in | Journal of animal science Vol. 95; no. 10; pp. 4510 - 4513 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Champaign
Oxford University Press
01.10.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Period2 (PER2), a core clock gene, encodes a circadian rhythm protein which has been shown to control mammary metabolism in rodents. Whether PER2 regulates milk component synthesis such as αs-casein protein in bovine mammary cells is unknown. Thus, we used gene silencing technology to determine if PER2 silencing could affect αs-casein synthesis and cell growth in cultured primary bovine mammary epithelial cells (BMEC). The BMEC were established by enzymatic digestion of mammary tissue from mid-lactation cows. A transient-transfection technique was used to insert a small interfering RNA (siRNA) oligonucleotide specific for PER2 to inhibit transcription. Control and siRNA-transfected cells were cultured for 48 h. qRT-PCR and ELISA analysis showed that PER2 silencing enhanced the synthesis of 2 kinds of αs-casein (P < 0.05) through upregulating the mRNA level of CSN1S1 and CSN1S2 (P < 0.01). Furthermore, the 3-(4, 5-dimethyl-2-thiazolyl)- 2, 5-diphenyl-2-H-tetrazolium bromide (MTT) results demonstrated that cell proliferation was not affected (P > 0.05). These data led us to hypothesize that PER2 protein may potentially play an important role in the control of milk protein synthesis and, hence, represents a target that can be used to regulate protein synthesis rate during lactation. |
---|---|
ISSN: | 0021-8812 1525-3163 |
DOI: | 10.2527/jas2017.1938 |